Policy makers should ‘set their sights higher’ on U.S. drug pricing regulations, researchers say
A review published in JAMA found that bills introduced into the House and Senate don’t go nearly as far as existing drug pricing regulations other countries. The researchers listed eight key lessons from six nations.
